Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators

Glial-origin brain tumors, including glioblastomas (GBM), have one of the worst prognoses due to their rapid and fatal progression. From an oncological point of view, advances in complete surgical resection fail to eliminate the entire tumor and the remaining cells allow a rapid recurrence, which do...

Descripción completa

Detalles Bibliográficos
Autores principales: Segura-Collar, Berta, Hiller-Vallina, Sara, de Dios, Olaya, Caamaño-Moreno, Marta, Mondejar-Ruescas, Lucia, Sepulveda-Sanchez, Juan M., Gargini, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171733/
https://www.ncbi.nlm.nih.gov/pubmed/37165457
http://dx.doi.org/10.1186/s40478-023-01569-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171733/
https://www.ncbi.nlm.nih.gov/pubmed/37165457
http://dx.doi.org/10.1186/s40478-023-01569-y

Ejemplares similares